Quorum Sensing Inhibitors: Curbing Pathogenic Infections through Inhibition of Bacterial Communication

Area of Science:

• Microbiology
• Infectious Diseases
• Drug Discovery

Background:

• Antibiotic overuse has led to the emergence of bacterial persisters, a subpopulation of microorganisms resistant to antibiotic treatment.
• Bacterial persisters communicate via Quorum Sensing (QS), a process regulating virulence and biofilm formation, which contributes to their survival and resistance.
• Targeting QS is a promising strategy to combat antibiotic resistance and re-sensitize bacteria to existing therapies.

Purpose of the Study:

• To review and summarize various approaches for identifying and developing Quorum Sensing (QS) inhibitors.
• To provide an overview of the origin, structural characteristics, and key interactions of known QS inhibitors.
• To highlight the potential of QS inhibitors in adjuvant therapy to combat infectious diseases.

Main Methods:

• Literature review of scientific articles and research papers on bacterial Quorum Sensing (QS) and QS inhibitors.
• Analysis of the mechanisms of action and structural features of identified QS inhibitors.
• Synthesis of information regarding the efficacy of QS inhibitors in preclinical and clinical studies.

Main Results:

• Several classes of QS inhibitors have been identified from natural and synthetic sources.
• Key molecular interactions responsible for QS inhibitory activity have been elucidated.
• QS inhibitors demonstrate potential in reducing bacterial virulence and increasing susceptibility to antibiotics.

Conclusions:

• Quorum Sensing (QS) inhibitors represent a viable strategy to overcome antibiotic resistance.
• Development of potent QS inhibitors could revitalize existing antibiotics for use in adjuvant therapy.
• Further research into QS inhibition is crucial for combating the growing threat of infectious diseases.